Soleno Therapeutics (SLNO) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.44% |
| Dec 31, 2025 | 55.48% |
| Sep 30, 2025 | 55.38% |
| Jun 30, 2025 | -14.15% |
| Mar 31, 2025 | -42.07% |
| Dec 31, 2024 | -36.41% |
| Sep 30, 2024 | -26.22% |
| Jun 30, 2024 | -35.27% |
| Mar 31, 2024 | -27.67% |
| Dec 31, 2023 | -11.05% |
| Sep 30, 2023 | -18.75% |
| Jun 30, 2023 | -15.14% |
| Mar 31, 2023 | -21.70% |
| Dec 31, 2022 | -80.33% |
| Sep 30, 2022 | -4.26% |
| Jun 30, 2022 | -29.76% |
| Mar 31, 2022 | -23.81% |
| Dec 31, 2021 | -39.59% |
| Sep 30, 2021 | -35.81% |
| Jun 30, 2021 | -14.68% |
| Mar 31, 2021 | -13.36% |
| Dec 31, 2020 | -16.98% |
| Sep 30, 2020 | -17.85% |
| Jun 30, 2020 | -19.33% |
| Mar 31, 2020 | -25.61% |
| Dec 31, 2019 | -26.70% |
| Sep 30, 2019 | -30.18% |
| Jun 30, 2019 | -27.50% |
| Mar 31, 2019 | -48.67% |
| Dec 31, 2018 | -38.92% |